Literature DB >> 8619593

In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci.

M Pestel1, E Martin, C Aucouturier, J F Lemeland, F Caron.   

Abstract

The effects of 16 different beta-lactam-fosfomycin combinations against 50 bloodstream enterococci were compared by a disk diffusion technique. Cefotaxime exhibited the best interaction. By checkerboard studies, the cefotaxime-fosfomycin combination provided a synergistic bacteriostatic effect against 45 of the 50 isolates (MIC of cefotaxime at which 90% of the isolates were inhibited, >2,048 micrograms/ml; MIC of fosfomycin at which 90% of the isolates were inhibited, 128 micrograms/ml; mean of fractional inhibitory concentration indexes, 0.195). By killing curves, cefotaxime (at 64 micrograms/ml) combined with fosfomycin (at > or = 64 micrograms/ml) was bactericidal against 6 of 10 strains tested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8619593      PMCID: PMC162940          DOI: 10.1128/AAC.39.10.2341

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci.

Authors:  P F Viladrich; F Gudiol; J Liñares; G Rufi; J Ariza; R Pallares
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

2.  Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci.

Authors:  V Barakett; D Lesage; F Delisle; B Burghoffer; G Richard; P Vergez; J C Petit
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

3.  Comparison of antibiotic combinations against penicillin-resistant pneumococci.

Authors:  B Cassinat; M H Nicolas
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

4.  Clinical pharmacokinetics of cefotaxime in patients with normal and reduced renal function.

Authors:  J T Doluisio
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

5.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

6.  In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.

Authors:  S Alvarez; M Jones; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

7.  Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus.

Authors:  Y Utsui; S Ohya; T Magaribuchi; M Tajima; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

8.  In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.

Authors:  H Grimm
Journal:  Infection       Date:  1979       Impact factor: 3.553

9.  [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].

Authors:  J M Duez; E Kohli; A Pechinot; J C Tremeaux; A Kazmierczak
Journal:  Pathol Biol (Paris)       Date:  1983-06

10.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

View more
  3 in total

1.  Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.

Authors:  Antonia C Kastoris; Petros I Rafailidis; Evridiki K Vouloumanou; Ioannis D Gkegkes; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2010-02-26       Impact factor: 2.953

2.  In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.

Authors:  S Rochon-Edouard; M Pestel-Caron; J F Lemeland; F Caron
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  A simple assay to screen antimicrobial compounds potentiating the activity of current antibiotics.

Authors:  Junaid Iqbal; Ruqaiyyah Siddiqui; Shahana Urooj Kazmi; Naveed Ahmed Khan
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.